95% CI, 0.78-0.95) and without type 2 diabetes (HR = 0.82
H., Chan A
ROS prioritizes patient education, transparency, and the ethical application of peptide therapy, offering treatments backed by scientific research and clinical experience
[DOI] [PMC free article] [PubMed] [Google Scholar] 136.Bianco A., Nigro E., Monaco M.L., Matera M.G., Scudiero O., Mazzarella G., Daniele A
(2024) outlined the wound-healing potential of collagen-based nanoparticles from a broad therapeutic perspective 73 , our study provides direct, quantitative evidence that QCN-HS achieves better fibroblast migration and gap-closure kinetics, surpassing the results reported for similar nanoparticle systems and clearly outperforming its non-encapsulated form
(August 2025, updated January 2026)